NantBioscience, Inc. develops molecularly targeted drugs based on the profile of the patient's tumor and drugs that remediate the activities of the often mutated tumor suppressor, p53. It develops a pipeline of nab-based molecules, and inh
NantBioscience, Inc.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://nanovelos.com
Founded2013
Disease Focus
Development Stage
STOCK CODENon Listed
Address9920 Jefferson Boulevard,California 90232Culver CityUnited States
9920 Jefferson Boulevard,California 90232
Culver City
United States
Contact Number+1 310-853-7888
+1 310-853-7888
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/nantbioscience” connections=”true” suffix=””]